Received Aug 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | FH8030 | OT |
had actual Covid - bad case but not hospitalized; had actual Covid - bad case but not hospitalized; This is a spontaneous report received from a Consumer or other non HCP. A 60-year-old female patient received BNT162b2 (BNT162B2), on 16Apr2021 as dose 1, single (Lot number: EW0164), in arm, on 07May2021 as dose 2, single (Lot number: EW0165), in arm and on 26Nov2021 as dose 3 (booster), single (Lot number: FH8030) at the age of 59 years, in arm, all intramuscular for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), in 2023 as dose number unknown (booster), single intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Strong Menopause symptoms" (unspecified if ongoing). There were no concomitant medications (the patient did not receive any other vaccines within 4 weeks prior to the first administration of the suspect vaccine, and did not receive any other vaccines on the same date as the Pfizer vaccine). The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "had actual Covid - bad case but not hospitalized". The patient underwent the following laboratory tests and procedures: Weight: 160. Clinical course: had actual Covid-bad case but not hospitalized in early 2023.
Medical History/Concurrent Conditions: Menopause
Test Name: weight; Result Unstructured Data: Test Result:160